Olaplex (NASDAQ:OLPX - Get Free Report)'s stock had its "sell (d)" rating reaffirmed by stock analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.
Other research analysts also recently issued reports about the stock. Barclays increased their target price on shares of Olaplex from $1.40 to $1.50 and gave the company an "equal weight" rating in a research report on Tuesday, July 15th. Telsey Advisory Group reaffirmed a "market perform" rating and issued a $2.00 target price on shares of Olaplex in a research report on Thursday, August 7th. Canaccord Genuity Group raised shares of Olaplex from a "hold" rating to a "buy" rating and raised their price objective for the stock from $1.50 to $2.00 in a research report on Monday, August 25th. Finally, Wall Street Zen raised shares of Olaplex from a "sell" rating to a "hold" rating in a research report on Saturday, July 12th. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $1.88.
Get Our Latest Research Report on Olaplex
Olaplex Price Performance
Shares of OLPX opened at $1.10 on Friday. Olaplex has a twelve month low of $1.01 and a twelve month high of $2.28. The firm's fifty day simple moving average is $1.35 and its 200-day simple moving average is $1.36. The firm has a market capitalization of $733.79 million, a price-to-earnings ratio of 27.50 and a beta of 2.31. The company has a current ratio of 3.86, a quick ratio of 3.20 and a debt-to-equity ratio of 0.40.
Olaplex (NASDAQ:OLPX - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by ($0.02). The firm had revenue of $106.28 million during the quarter, compared to analyst estimates of $100.30 million. Olaplex had a negative net margin of 0.30% and a positive return on equity of 3.32%. Olaplex's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.03 earnings per share. Olaplex has set its FY 2025 guidance at EPS. Equities analysts forecast that Olaplex will post 0.1 EPS for the current fiscal year.
Institutional Trading of Olaplex
Hedge funds and other institutional investors have recently made changes to their positions in the company. R Squared Ltd purchased a new stake in shares of Olaplex in the second quarter valued at about $25,000. Teacher Retirement System of Texas purchased a new stake in shares of Olaplex in the first quarter valued at about $25,000. Hsbc Holdings PLC boosted its holdings in shares of Olaplex by 80.6% in the first quarter. Hsbc Holdings PLC now owns 35,902 shares of the company's stock valued at $46,000 after acquiring an additional 16,023 shares in the last quarter. Creative Planning boosted its holdings in shares of Olaplex by 35.0% in the second quarter. Creative Planning now owns 37,357 shares of the company's stock valued at $52,000 after acquiring an additional 9,690 shares in the last quarter. Finally, CWM LLC boosted its holdings in shares of Olaplex by 506.8% in the third quarter. CWM LLC now owns 47,000 shares of the company's stock valued at $62,000 after acquiring an additional 39,254 shares in the last quarter. Hedge funds and other institutional investors own 87.37% of the company's stock.
Olaplex Company Profile
(
Get Free Report)
Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Olaplex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olaplex wasn't on the list.
While Olaplex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.